in the Q3/2018, the company and its subsidiaries have the total revenue from sales in amount of Baht 2,880.2 million which is decreasing from the 2017 at equivalence of Baht 402.8 million, about 12

the time of this report, there is a total of Baht 2,270 million in property sales revenue which will be recognized in the future barring any cancellations. • Other income increased by Baht 108 million

. other income) 49% 50% 48% (2%) (1%) 49% 50% 1% Operating Profit Margin (exc. non-recurring item) 37% 37% 37% 0% 0% 38% 39% 1% Consolidated Earnings (THB mn) % Change QoQ (2Q17 vs 3Q17) % Change YoY (3Q16

-53.16 6.02 20.10 -70.07 Other income 20.93 29.96 -30.13 52.03 56.91 -8.58 Total revenues 729.35 1,044.72 -30.19 373.01 571.12 -34.69 Cost of real estate sales 488.32 712.37 -31.45 211.53 360.70 -41.36

5.37 Million Baht or 2.65% decrease from the same period last year. This was the result from Order OEM brand Keen and Order OEM Injection Plastic reduced. 2. Other Income totaling 7.25 Million Baht was

34.44 million or 0.04 Baht per share, representing a total increase in profit of Baht 6.68 million or 19% of the previous year mainly came from the significant transactions as below : 1. The revenue from

ratio of recurring income to total revenue, (3) allowing REITs to seek circular resolutions (not including the resolution on sale of assets), (4) reducing the time required for delivering documents

Public Company Limited (“NMG”), which involved bear no relationship and are not related persons of the Company. Details of the assets acquired Ordinary shares of 42,250,000 shares, representing 84.50% of

49.34 17.69% Finance cost 49.11 68.10 18.99 38.67% Income tax expenses 48.04 57.52 9.48 19.73% Net profit 181.71 202.58 20.87 11.49% Net profit ratio (ROS) 17.16% 15.74% Earnings per share (Baht) 0.34

subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st